Trials / Not Yet Recruiting
Not Yet RecruitingNCT06491628
Liver Function Abnormalities in Patients With Acute Heart Failure
Liver Function Abnormalities in Patients With Acute Heart Failure in Sohag University Hospitals
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Sohag University · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- —
Summary
The aim of this study is to evaluate liver function test abnormalities and to identify associated cardiac and non cardiac factors mediating hepatic impairment in acute heart failure patients
Detailed description
Cardiac failure has a negative impact on the function of all parenchymatous organs, based both on the low organ perfusion in the left-sided failure and on the venous congestion in the right-sided failure. The pathophysiology of acute heart failure (AHF) is complex and not fully understood. It has been hypothesized that an episode of acute decompensation affects not only the cardiovascular system itself, but may also deteriorate the function of other organs, c ausing serious clinical consequences. Liver involvement has been mostly described and investigated in patients with chronic HF. Liver enzyme alterations are usually classified as relating predominantly to liver cell necrosis (signified by transaminase elevations) or predominantly to cholestasis (signified by elevated alkaline phosphatase (AP) level).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Avoiding the risk factors | Exercise, Salt and lipid reduction in diet, smoking cessation |
Timeline
- Start date
- 2024-07-01
- Primary completion
- 2025-07-01
- Completion
- 2025-08-01
- First posted
- 2024-07-09
- Last updated
- 2024-07-10
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06491628. Inclusion in this directory is not an endorsement.